The Feds Are 'Playing Nice' With Pharma, at Least for Now
Big pharma emerged relatively unscathed from Medicare price negotiations, but that might not always be the case.
Big pharma emerged relatively unscathed from Medicare price negotiations, but that might not always be the case.
/cloudfront-us-east-1.images.arcpublishing.com/gray/BFMUKWSWURCKTM4CQOY4DVUYOA.jpg)
